BIOMARIN PHARMACEUTICAL INC Weighted Average Number of Shares Outstanding, Basic and Diluted
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 177.48 million shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2018-10-26
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 177.48M shares, a 1.36% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-06-30 was 176.87M shares, a 1.43% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-09-30 was 175.10M shares.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-06-30 was 174.37M shares, a 7.25% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 160.03M shares, a 9.34% increase from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 146.35M shares, a 6.24% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 137.75M shares, a 14.54% increase from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 120.27M shares, a 7.27% increase from fiscal 2011.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2018-09-30 | 177.48M shares 10-Q · filed 2018-10-26 | 177.18M shares derived: average of 2 quarters · filed 2018-10-26 | 176.77M shares 10-Q · filed 2018-10-26 | |
| 2018-06-30 | 176.87M shares 10-Q · filed 2018-08-03 | 176.41M shares 10-Q · filed 2018-08-03 | ||
| 2017-09-30 | 175.10M shares 10-Q · filed 2018-10-26 | 174.74M shares derived: average of 2 quarters · filed 2018-10-26 | 174.07M shares 10-Q · filed 2018-10-26 | |
| 2017-06-30 | 174.37M shares 10-Q · filed 2018-08-03 | 173.55M shares 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | 172.71M shares 10-Q · filed 2017-05-04 | |||
| 2016-06-30 | 162.59M shares 10-Q · filed 2017-08-02 | 162.07M shares 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | 161.55M shares 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | 160.03M shares 10-K · filed 2016-02-29 | |||
| 2015-06-30 | 160.41M shares 10-Q · filed 2016-08-08 | 159.02M shares 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | 157.61M shares 10-Q · filed 2016-05-02 | |||
| 2014-12-31 | 146.35M shares 10-K · filed 2016-02-29 | |||
| 2013-12-31 | 142.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 141.75M shares derived: average of 2 quarters · filed 2016-02-29 | 137.75M shares 10-K · filed 2016-02-29 | |
| 2013-09-30 | 140.80M shares 10-Q · filed 2013-10-28 | 136.10M shares 10-Q · filed 2013-10-28 | ||
| 2013-03-31 | 127.97M shares 10-Q · filed 2013-04-29 | 126.31M shares derived: average of 2 quarters · filed 2015-03-02 | 125.35M shares derived: average of 3 quarters · filed 2015-03-02 | 123.49M shares derived: average of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | 124.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 124.04M shares derived: average of 2 quarters · filed 2015-03-02 | 122.00M shares derived: average of 3 quarters · filed 2015-03-02 | 120.27M shares 10-K · filed 2015-03-02 |
| 2012-09-30 | 123.43M shares 10-Q · filed 2013-10-28 | 120.67M shares derived: average of 2 quarters · filed 2013-10-28 | 118.81M shares 10-Q · filed 2013-10-28 | 117.71M shares derived: average of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | 117.91M shares 10-Q · filed 2012-08-02 | 116.50M shares 10-Q · filed 2012-08-02 | 115.80M shares derived: average of 3 quarters · filed 2014-02-26 | 114.92M shares derived: average of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | 115.07M shares 10-Q · filed 2013-04-29 | 114.74M shares derived: average of 2 quarters · filed 2014-02-26 | 113.92M shares derived: average of 3 quarters · filed 2014-02-26 | 113.22M shares derived: average of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | 114.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | 113.35M shares derived: average of 2 quarters · filed 2014-02-26 | 112.61M shares derived: average of 3 quarters · filed 2014-02-26 | 112.12M shares 10-K · filed 2014-02-26 |
| 2011-09-30 | 112.29M shares 10-Q · filed 2012-10-29 | 111.70M shares derived: average of 2 quarters · filed 2012-10-29 | 111.36M shares 10-Q · filed 2012-10-29 | |
| 2011-06-30 | 111.11M shares 10-Q · filed 2012-08-02 | 110.88M shares 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |